Dulazar (Anidulafungin) Injection

Description

Description

This page contains brief details about the drug anidulafungin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Anidulafungin is an antifungal medication developed by the U.S. Food And Drug Administration and initially approved on 21 Feb 2006 for treating serious fungal infections.

Mechanism of Action of Anidulafungin

Anidulafungin works by inhibiting the beta-glucan synthesis in the cell walls of susceptible fungi. This disruption weakens the fungal cell wall, leading to the death of the fungus.

Uses of Anidulafungin

Anidulafungin helps to treat certain invasive fungal infections. It is effective against various types of invasive candidiasis, such as candidemia (Candida bloodstream infection) and esophageal candidiasis (fungal infection affecting the esophagus). Invasive candidiasis occurs when candida yeasts enter the bloodstream or other internal organs and cause systemic infections.

Anidulafungin Dosage available

Anidulafungin is administered directly into the vein intravenously (IV). It is available as a powder for reconstitution, and a physician will prepare and administer the medication through a vein. The IV infusion is usually given over a period of one to two hours.